These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1577849)
41. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Tartour E; Mosseri V; Jouffroy T; Deneux L; Jaulerry C; Brunin F; Fridman WH; Rodriguez J Lancet; 2001 Apr; 357(9264):1263-4. PubMed ID: 11418153 [TBL] [Abstract][Full Text] [Related]
42. Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients. Schmidt M; Hoppe F Acta Otolaryngol; 1999; 119(8):949-53. PubMed ID: 10728940 [TBL] [Abstract][Full Text] [Related]
43. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival. Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115 [TBL] [Abstract][Full Text] [Related]
44. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516 [TBL] [Abstract][Full Text] [Related]
45. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma. Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866 [TBL] [Abstract][Full Text] [Related]
46. Prognostic value of albumin in patients with head and neck cancer. Danan D; Shonka DC; Selman Y; Chow Z; Smolkin ME; Jameson MJ Laryngoscope; 2016 Jul; 126(7):1567-71. PubMed ID: 26864349 [TBL] [Abstract][Full Text] [Related]
47. Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer. Gleich LL; Srivastava L; Gluckman JL Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):710-2. PubMed ID: 8800057 [TBL] [Abstract][Full Text] [Related]
48. Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results. He S; Li P; He S; Long T; Zhang N; Fang J; Yu Z J Laryngol Otol; 2013 Aug; 127(8):788-93. PubMed ID: 23835309 [TBL] [Abstract][Full Text] [Related]
49. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma. Baumeister P; Canis M; Reiter M PLoS One; 2018; 13(10):e0205712. PubMed ID: 30347001 [TBL] [Abstract][Full Text] [Related]
50. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Woolley AL; Hogikyan ND; Gates GA; Haughey BH; Schechtman KB; Goldenberg JL Ann Otol Rhinol Laryngol; 1992 Sep; 101(9):724-30. PubMed ID: 1387516 [TBL] [Abstract][Full Text] [Related]
51. Prognostic value of initial mononucleated cell percentages in patients with epidermoid carcinoma of the head and neck. Elias EG; Leuchten JM; Buda BS; Brown SD Am J Surg; 1986 Nov; 152(5):487-90. PubMed ID: 3777326 [TBL] [Abstract][Full Text] [Related]
52. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788 [TBL] [Abstract][Full Text] [Related]
53. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck. Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049 [TBL] [Abstract][Full Text] [Related]
54. Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas. Muriel VP; Tejada MR; de Dios Luna del Castillo J Radiother Oncol; 2001 Aug; 60(2):137-45. PubMed ID: 11439208 [TBL] [Abstract][Full Text] [Related]
55. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution. Santos AB; Cernea CR; Inoue M; Ferraz AR Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434 [TBL] [Abstract][Full Text] [Related]
56. [Effect of the levels of vascular endothelial growth factor-A and C on the prognosis of patients with laryngeal carcinoma]. Düzen B; Taş A; Demir M; Usta U; Yağız R; Koten M; Karasalihoğlu A Kulak Burun Bogaz Ihtis Derg; 2011; 21(3):122-8. PubMed ID: 21595615 [TBL] [Abstract][Full Text] [Related]
57. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Wang Z; Cui K; Xue Y; Tong F; Li S Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596 [TBL] [Abstract][Full Text] [Related]
58. Immunosuppressive substance in the sera of head and neck cancer patients. Yamanaka N; Harabuchi Y; Himi T; Kataura A Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271 [TBL] [Abstract][Full Text] [Related]
59. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma. Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503 [TBL] [Abstract][Full Text] [Related]
60. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma. Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]